ARTICLE | Company News
Stressgen, Ampersand Ventures deal
April 18, 2005 7:00 AM UTC
SSB will sell its bioreagents business to Stressgen BioReagents Corp. for C$8 million (US$6.5 million). Stressgen BioReagents was formed by Ampersand. The sale will include 26 SSB employees. ...